Hidradenitis Suppurativa Written Action Plan

Overview

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

Full Title of Study: “Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 15, 2021

Interventions

  • Behavioral: Verbal consultation
    • Verbal consultation only without written information before receiving written action plan
  • Behavioral: Written Action Plan
    • Written handout of treatment plan and disease management strategies

Arms, Groups and Cohorts

  • Other: Verbal Consultation, then Written Action Plan
    • CONTROL GROUP Survey A Routine clinic visit Verbal consultation only Survey B Verbal consultation AND Written Action Plan Survey C
  • Experimental: Written Action Plan
    • INTERVENTION GROUP Survey A Routine clinic visit Verbal consultation AND Written Action Plan Survey C

Clinical Trial Outcome Measures

Primary Measures

  • Visits to high-cost care settings
    • Time Frame: 12 months
    • Number of visits to ER, urgent care, or hospitalizations because of HS

Participating in This Clinical Trial

Inclusion Criteria

  • Has a diagnosis of HS

Exclusion Criteria

  • Has been exposed to a written action plan for HS before

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Arizona
  • Provider of Information About this Clinical Study
    • Principal Investigator: Vivian Shi, MD – University of Arizona
  • Overall Contact(s)
    • Vivian Y Shi, 5206948888, vshi@email.arizona.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.